by The global respiratory monitoring devices market size is forecasted to reach from US$ 1.62 billion in 2021 to US$ 2.95 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 6.9% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2021 to 2030. The respiratory monitoring devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1423
The demand for the respiratory monitoring devices is expected to grow at a promising rate in the forthcoming years owing to the rising prevalence of various respiratory diseases. The alarming rising in the incidences of chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections across the globe is boosting the growth of the global respiratory monitoring devices market. According to the World Health Organization, around 65 million people across the globe suffers from COPD and around 3 million dies due to it every year. Around 334 million people are suffering from asthma and around 14% of the global children are affected from it.
The rising pollution levels, rising demand for tobacco smoking, and changing lifestyle of the consumers are the major contributors to the surging cases of respiratory diseases among the global population. The manufacturers are investing in the development of the wearable sensors that can efficiently monitor the respiration rate. The increasing focus on making comfortable and convenient devices for the patients is expected to drive the demand for the various innovative respiratory monitoring devices in the forthcoming years. Furthermore, the integration of the latest technologies like integration of the smartphone technology with the pulse oximeters is driving the growth of the market.
Scope of the Respiratory Monitoring Devices Market Report
| Report Coverage | Details |
| Market Size in 2020 | USD 1.53 billion |
| Growth Rate | CAGR of 6.9% From 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Device Type, End User, Indication, Region |
Competitive Landscape Analysis:
Some of the leading companies operating in the respiratory monitoring devices market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- Medtronic
- GE Healthcare
- Masimo
- Philips Healthcare
- Welch Allyn, Inc.
- Smiths Medical
- MGC Diagnostics Corporation
- Novelda AS
- Dragerwerk AG & Co. KGaA
- Nihon Kohden Corporation
Hospitals to be Major End User of Respiratory Monitoring Devices
Based on end-user, the global respiratory monitoring devices market has been categorized into hospitals, clinics and home care,
The home care segment is likely to gain significant market share by 2030. The growth of this segment can be attributed to the increase in the adoption of respiratory monitoring devices for home use, the rise in the number of market players launching portable devices, and the growing demand for home use spirometers and peak flow meters.
Market Segmentation
By Device Type
- Capnography
- Peak Flow Meters
- Pulse Oximeters
- Spirometers
- Gas Analyzers
- Polysomnography
- Others
By Indication
- Sleep Apnea
- COPD
- Asthma
- Infectious Disease
By End User
- Hospitals
- Clinics
- Homecare
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global respiratory monitoring devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for respiratory monitoring devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1423
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Respiratory Monitoring Devices Market
5.1. COVID-19 Landscape: Respiratory Monitoring Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Respiratory Monitoring Devices Market, By Indication
8.1. Respiratory Monitoring Devices Market, by Indication Type, 2021-2030
8.1.1. Sleep Apnea
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. COPD
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Asthma
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Infectious Disease
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Respiratory Monitoring Devices Market, By Device
9.1. Respiratory Monitoring Devices Market, by Device, 2021-2030
9.1.1. Capnography
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Peak Flow Meters
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Pulse Oximeters
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Spirometers
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Gas Analyzers
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Polysomnography
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Respiratory Monitoring Devices Market, By End User
10.1. Respiratory Monitoring Devices Market, by End User, 2021-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Homecare
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Respiratory Monitoring Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Indication (2019-2030)
11.1.2. Market Revenue and Forecast, by Device (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Indication (2019-2030)
11.2.2. Market Revenue and Forecast, by Device (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Indication (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Device (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Indication (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Device (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Indication (2019-2030)
11.3.2. Market Revenue and Forecast, by Device (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Indication (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Device (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Indication (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Device (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Indication (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Device (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Indication (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Device (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Indication (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Device (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Indication (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Device (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Medtronic
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Masimo
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Philips Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Welch Allyn, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Smiths Medical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. MGC Diagnostics Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Novelda AS
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Dragerwerk AG & Co. KGaA
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Nihon Kohden Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1423
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
